Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic.
coronavirus disease
heart failure
ventricular assist device
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
13 Jan 2022
13 Jan 2022
Historique:
received:
16
12
2021
revised:
08
01
2022
accepted:
10
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ involvement, including the cardiovascular system. The disease may cause several cardiovascular complications, and may increase morbidity and mortality among patients with background cardiovascular disease. Patients with advanced heart failure are often treated with left ventricular assist device (LVAD), and represent a unique population mandating multi-disciplinary approach. Several aspects of COVID-19 should be taken into account in LVAD implants, including right ventricular involvement, hemodynamic alterations, thromboembolic and haemorrhagic complications, and the psychological effects of social isolation. Patients with VAD and suspected COVID-19 should be transferred to specialized centers for better management of complications. Here, we review the implications of COVID-19 pandemic on LVAD patients with our recommendations for appropriate management.
Identifiants
pubmed: 35056424
pii: medicina58010116
doi: 10.3390/medicina58010116
pmc: PMC8781665
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Heart Lung. 2020 Nov - Dec;49(6):688-691
pubmed: 32861886
Eur J Heart Fail. 2020 Jun;22(6):937-940
pubmed: 32437041
ESC Heart Fail. 2020 Sep 30;:
pubmed: 32997438
Sci Rep. 2021 Sep 7;11(1):17774
pubmed: 34493763
Heart Fail Rev. 2021 Jul;26(4):973-979
pubmed: 33405001
Heart Lung. 2020 Nov - Dec;49(6):808-811
pubmed: 33010519
Eur Heart J Case Rep. 2021 Mar 07;5(3):ytaa447
pubmed: 33733044
BMC Infect Dis. 2021 Aug 21;21(1):855
pubmed: 34418980
J Artif Organs. 2021 Aug 1;:
pubmed: 34333741
J Card Surg. 2020 Nov;35(11):3231-3234
pubmed: 32827186
JACC Case Rep. 2020 Jul 15;2(9):1315-1320
pubmed: 32292915
ASAIO J. 2021 Nov 1;67(11):1189-1195
pubmed: 34475334
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008
pubmed: 32270559
Circulation. 2017 May 23;135(21):2003-2012
pubmed: 28385948
Circ Heart Fail. 2021 Apr;14(4):e007957
pubmed: 33813838
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Int J Cardiol. 2021 Mar 15;327:251-258
pubmed: 33242508
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1038-1050
pubmed: 32364221
Lancet. 2020 Oct 10;396(10257):1071-1078
pubmed: 32987008
J Card Fail. 2020 Jul;26(7):639
pubmed: 32525070
J Card Surg. 2020 Nov;35(11):3202-3204
pubmed: 32789890
Clin Immunol. 2020 Dec;221:108614
pubmed: 33153974
JACC Case Rep. 2020 Jul 15;2(9):1337-1341
pubmed: 32835275
J Card Fail. 2020 Oct;26(10):895-897
pubmed: 32956813
Eur J Heart Fail. 2020 Jun;22(6):933-936
pubmed: 32391963
CJC Open. 2021 May 26;3(10):1249-1256
pubmed: 34056570
J Card Surg. 2021 Sep;36(9):3405-3409
pubmed: 34091934
Eur Heart J Case Rep. 2021 May 12;5(5):ytab144
pubmed: 34013162
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Ann Cardiothorac Surg. 2018 Jan;7(1):3-11
pubmed: 29492379
J Card Fail. 2020 May;26(5):438-439
pubmed: 32305569